An Open Label, Pilot Study Evaluating the Efficacy and Safety of the Use of Nasal Carbon Dioxide for the Treatment of Episodic Cluster Headache
Phase of Trial: Phase II
Latest Information Update: 11 May 2017
At a glance
- Drugs Carbon dioxide (Primary)
- Indications Cluster headache
- Focus Therapeutic Use
- 12 Apr 2017 Status changed from recruiting to discontinued.
- 09 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 03 Feb 2016 New trial record